Patents by Inventor Wafa Tawackoli

Wafa Tawackoli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11318166
    Abstract: Described herein are methods and compositions using PTH and mesenchymal stem cells (MSCs) for treatment of osteoporosis, bone fractures, and related conditions. Administration of both PTH and MSCs leads to increased homing of MSCs to sites of vertebral bone and rib fracture. The described methods and compositions provide therapeutic approaches that rely, in-part, on stem cell capacity for regeneration and repair. The potential for enhanced bone formation and fracture repair may allow for both preventative and palliative treatments in osteoporotic patients, with combined PTH+MSC therapy producing bone regeneration capacity that is significantly superior to either treatment alone.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: May 3, 2022
    Assignee: Cedars-Sinai Medical Center
    Inventors: Dan Gazit, Edward M. Schwarz, Hyun Bae, Gadi Pelled, Zulma Gazit, Dmitriy Sheyn, Wafa Tawackoli
  • Patent number: 10638948
    Abstract: The present invention teaches novel methods of diagnosing and prognosing conditions associated with tissue degeneration and/or pain, including intervertebral disc degeneration, discogenic pain, osteoarthritis, rheumatoid arthritis, and articular cartilage injury. Using the inventive noninvasive imaging methods, the diagnosis and prognosis of back pain and related conditions can be quickly and accurately determined by detecting one or more biomarkers disclosed herein.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: May 5, 2020
    Assignee: CEDARS-SINAI MEDICAL CENTER
    Inventors: Dan Gazit, Debiao Li, Hyun Bae, Gadi Pelled, Zulma Gazit, Qi Liu, Wafa Tawackoli
  • Publication number: 20170119823
    Abstract: Described herein are methods and compositions using PTH and mesenchymal stem cells (MSCs) for treatment of osteoporosis, bone fractures, and related conditions. Administration of both PTH and MSCs leads to increased homing of MSCs to sites of vertebral bone and rib fracture. The described methods and compositions provide therapeutic approaches that rely, in-part, on stem cell capacity for regeneration and repair. The potential for enhanced bone formation and fracture repair may allow for both preventative and palliative treatments in osteoporotic patients, with combined PTH+MSC therapy producing bone regeneration capacity that is significantly superior to either treatment alone.
    Type: Application
    Filed: June 4, 2015
    Publication date: May 4, 2017
    Applicant: Cedars-Sinai Medical Center
    Inventors: Dan Gazit, Edward M. Schwarz, Hyun Bae, Gadi Pelled, Zulma Gazit, Dmitriy Sheyn, Wafa Tawackoli
  • Publication number: 20160081578
    Abstract: The present invention teaches novel methods of diagnosing and prognosing conditions associated with tissue degeneration and/or pain, including intervertebral disc degeneration, discogenic pain, osteoarthritis, rheumatoid arthritis, and articular cartilage injury. Using the inventive noninvasive imaging methods, the diagnosis and prognosis of back pain and related conditions can be quickly and accurately determined by detecting one or more biomarkers disclosed herein.
    Type: Application
    Filed: April 18, 2014
    Publication date: March 24, 2016
    Applicant: Cedars-Sinai Medical Center
    Inventors: Dan Gazit, Debiao Li, Hyun Bae, Gadi Pelled, Zulma Gazit, Qi Liu, Wafa Tawackoli